Arthur Ryan, a Director at Regeneron Pharmaceuticals Inc (REGN), recently sold 100 shares of the company, reducing his stake to 17,803 shares. Over the past year, Regeneron has seen five insider sells and no insider buys. The stock is currently priced at $778.53, and GuruFocus classifies it as modestly undervalued with a GF Value of $932.22.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Insider Selling: Arthur Ryan Sells Shares of Regeneron Pharmaceu
Arthur Ryan, a Director at Regeneron Pharmaceuticals Inc (REGN), recently sold 100 shares of the company, reducing his stake to 17,803 shares. Over the past year, Regeneron has seen five insider sells and no insider buys. The stock is currently priced at $778.53, and GuruFocus classifies it as modestly undervalued with a GF Value of $932.22.